10th week of 2020 patent applcation highlights part 10 |
Patent application number | Title | Published |
20200069674 | TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF | 2020-03-05 |
20200069675 | PHARMACEUTICAL PREPARATIONS OF SEBACOYL DINALBUPHINE AND ACETAMINOPHEN AND METHODS FOR TREATING PAIN | 2020-03-05 |
20200069676 | METHODS OF SAFELY TRANSITIONING A SUBJECT TO BUPRENORPHINE | 2020-03-05 |
20200069677 | MARKERS FOR PERSONALIZED CANCER TREATMENT WITH LSD1 INHIBITORS | 2020-03-05 |
20200069678 | PHARMACEUTICAL COMPOSITION OF ORAL SUSPENSION OF ANTI-NEOPLASTIC ALKYLATING AGENTS | 2020-03-05 |
20200069679 | NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLADATEROL | 2020-03-05 |
20200069680 | OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE | 2020-03-05 |
20200069681 | CANNABINOID RECEPTOR MODULATORS | 2020-03-05 |
20200069682 | PARP-1 AND METHODS OF USE THEREOF | 2020-03-05 |
20200069683 | NOVEL METHODS | 2020-03-05 |
20200069684 | THERAPEUTIC AGENT FOR TUMORS IDENTIFIED BY PHOSPHORYLATION OF PROTO-ONCOGENE PROTEIN BELONGING TO VAV FAMILY | 2020-03-05 |
20200069685 | Dosing schedule for a combination of Ceritinib and an anti-PD-1 antibody molecule | 2020-03-05 |
20200069686 | N-SUBSTITUTED INDOLE DERIVATIVES | 2020-03-05 |
20200069687 | Inhibitors of Multidrug Resistance Transporter P-Glycoprotein | 2020-03-05 |
20200069688 | METHODS FOR THE TREATMENT OF CANCER | 2020-03-05 |
20200069689 | QUINAZOLINE-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS | 2020-03-05 |
20200069690 | ARYLQUINAZOLINES | 2020-03-05 |
20200069691 | HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS | 2020-03-05 |
20200069692 | BOVINE SUPPLEMENT FOR NEONATAL CALVES | 2020-03-05 |
20200069693 | DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION | 2020-03-05 |
20200069694 | METHODS OF TREATING METASTATIC BREAST CANCER WITH TRASTUZUMAB-MCC-DM1 | 2020-03-05 |
20200069695 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE | 2020-03-05 |
20200069696 | OPHTHALMIC INJECTABLE FORMULATION PREPARING AND OCULOPATHY TREATING AND PREVENTING | 2020-03-05 |
20200069697 | TREATMENT OF CANCER AND INHIBITION OF METASTASIS | 2020-03-05 |
20200069698 | TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE | 2020-03-05 |
20200069699 | COMPOSITIONS AND METHODS FOR REDUCING BODY FAT | 2020-03-05 |
20200069700 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | 2020-03-05 |
20200069701 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2020-03-05 |
20200069702 | ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING AN UNMICRONIZED SELECTIVE PROGESTERONE RECEPTOR AS ACTIVE AGENT | 2020-03-05 |
20200069703 | CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE | 2020-03-05 |
20200069704 | Methods Of Treating Prostate Cancer | 2020-03-05 |
20200069705 | NOVEL PARASITE THERAPY | 2020-03-05 |
20200069706 | PRODRUGS OF 2-PMPA FOR HEALTHY TISSUE PROTECTION DURING PSMA-TARGETED CANCER IMAGING OR RADIOTHERAPY | 2020-03-05 |
20200069707 | COMPOSITIONS AND PRODUCTS FOR USE IN THE TREATMENT OF BONE FRACTURES AND DEFECTS | 2020-03-05 |
20200069708 | TOPICAL ANTIVIRAL FORMULATIONS | 2020-03-05 |
20200069709 | SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION | 2020-03-05 |
20200069710 | COMPOSITIONS FOR TREATMENT OF HYPERGLYCEMIA IN DIABETES MELLITUS PATIENTS | 2020-03-05 |
20200069711 | TREATING AND PREVENTING KIDNEY DAMAGE | 2020-03-05 |
20200069712 | PHARMACEUTICAL COMPOUNDS AND USES THEREOF | 2020-03-05 |
20200069713 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2020-03-05 |
20200069714 | AMINOGLYCOSIDE POTENTIATION FOR TREATMENT OF PULMONARY BACTERIAL INFECTION | 2020-03-05 |
20200069715 | BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES | 2020-03-05 |
20200069716 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | 2020-03-05 |
20200069717 | NUCLEOTIDE DERIVATIVES AND METHODS OF USE THEREOF | 2020-03-05 |
20200069718 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER WITH 5-IODO-2-PYRIMIDINONE-2'(prime)-DEOXYRIBOSE (IPdR) | 2020-03-05 |
20200069719 | Edible Energy Composition | 2020-03-05 |
20200069720 | MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes | 2020-03-05 |
20200069721 | STAUFEN1 AGENTS AND ASSOCIATED METHODS | 2020-03-05 |
20200069722 | ALLELE SPECIFIC MODULATORS OF P23H RHODOPSIN | 2020-03-05 |
20200069723 | COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF | 2020-03-05 |
20200069724 | Myrtle Polysaccharide P1, the Separation Method Thereof and the Use in Preparing Hypolipidemic Drugs Therefor | 2020-03-05 |
20200069725 | HYALURONAN COMPOSITIONS, AND USES THEREOF IN TREATMENT OF INTERSTITIAL CYSTITIS | 2020-03-05 |
20200069726 | ALGINATE LIQUID PREPARATION | 2020-03-05 |
20200069727 | CALCIUM PEROXIDES NANOPARTICLES AS ADJUVANT THERAPY | 2020-03-05 |
20200069728 | HYPOCHLOROUS ACID BASED EYE DROP AND OPHTHALMIC COMPOSITION | 2020-03-05 |
20200069729 | Combination Therapy for Treating Proliferative Diseases | 2020-03-05 |
20200069730 | PHARMACEUTICAL PREPARATION AND MEDICAL DEVICE | 2020-03-05 |
20200069731 | METHODS AND COMPOSITIONS OF TREATING AUTOIMMUNE DISEASES | 2020-03-05 |
20200069732 | MODULATION OF CELL FUNCTION FOR IMMUNOTHERAPY | 2020-03-05 |
20200069733 | FLT3L-BASED CHIMERIC PROTEINS | 2020-03-05 |
20200069734 | ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF | 2020-03-05 |
20200069735 | TARGETED DISRUPTION OF THE MHC CELL RECEPTOR | 2020-03-05 |
20200069736 | IN VITRO PRODUCTION OF RED BLOOD CELLS WITH PROTEINS COMPRISING SORTASE RECOGNITION MOTIFS | 2020-03-05 |
20200069737 | NANOFRACTION IMMUNE MODULATORS, PREPARATIONS AND COMPOSITIONS INCLUDING THE SAME, AND ASSOCIATED METHODS | 2020-03-05 |
20200069738 | EXTRACELLULAR MATRIX (ECM) HYDROGEL AND SOLUBLE FRACTION THEREOF FOR THE TREATMENT OF CANCER | 2020-03-05 |
20200069739 | IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS | 2020-03-05 |
20200069740 | ROR1-POSITIVE MESENCHYMAL STEM CELL-CONTAINING PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASE ASSOCIATED WITH FIBROSIS, METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE ASSOCIATED WITH FIBROSIS USING ROR1-POSITIVE MESENCHYMAL STEM CELLS | 2020-03-05 |
20200069741 | Methods for the Treatment of Autism Spectrum Disorders | 2020-03-05 |
20200069742 | METHODS FOR ALLEVIATING, INHIBITING OR REVERSING MUSCLE DISUSE ATROPHY IN MAMMALS | 2020-03-05 |
20200069743 | METHOD OF AMELIORATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING PARABACTEROIDES GOLDSTEINII | 2020-03-05 |
20200069744 | COMBINATION PROBIOTIC COMPOSITIONS AND USES THEREOF | 2020-03-05 |
20200069745 | METHOD OF AMELIORATING CHRONIC KIDNEY DISEASE USING PARABACTEROIDES GOLDSTEINII | 2020-03-05 |
20200069746 | NOVEL PROBIOTICS BIFIDOBACTERIA STRAINS | 2020-03-05 |
20200069747 | PROBIOTIC COMPOSITIONS AND USES THEREOF | 2020-03-05 |
20200069748 | HUMAN-DERIVED LACTOBACILLUS FREMENTUM MG4231 OR LACTOBACILLUS FREMENTUM MG4244 STRAIN HAVING ANTI-OBESITY ACTIVITY AND COMPOSITION COMPRISING SAME | 2020-03-05 |
20200069749 | LACTOBACILLUS-BASED ECOLI INHIBITION | 2020-03-05 |
20200069750 | EXTRACTS FROM ARTHROSPIRA AND USES THEREOF | 2020-03-05 |
20200069751 | DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF | 2020-03-05 |
20200069752 | CANCER IMMUNOTHERAPY USING VIRUS PARTICLES | 2020-03-05 |
20200069753 | GENE THERAPY FOR CILIOPATHIES | 2020-03-05 |
20200069754 | Botanical Extract for Skin Care | 2020-03-05 |
20200069755 | Anti-Inflammatory Botanical Extract | 2020-03-05 |
20200069756 | OPTILUMINE COMPOSITION | 2020-03-05 |
20200069757 | LOW TOXIC TRIPTERYGIUM NEOGLYCOSIDES, PREPARATION METHOD AND APPLICATION THEREOF | 2020-03-05 |
20200069758 | COMPOSITION FOR USE IN THE PREVENTIVE AND/OR CURATIVE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020-03-05 |
20200069759 | Botanical Antioxidants | 2020-03-05 |
20200069760 | PERCYTE COMPOSITION | 2020-03-05 |
20200069761 | HAND SANITIZER COMPOSITION AND METHOD OF MANUFACTURE | 2020-03-05 |
20200069762 | COMPOSITIONS OF HYDROLYZED COLLAGEN PEPTIDES AND COMMENSAL MICROORGANISMS AND METHODS THEREOF | 2020-03-05 |
20200069763 | DERMAGRANT COMPOSITION | 2020-03-05 |
20200069764 | ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION | 2020-03-05 |
20200069765 | PEPTIDES HAVING IMMUNOMODULATORY PROPERTIES | 2020-03-05 |
20200069766 | COMPETITIVE INHIBITORS OF INVARIANT CHAIN EXPRESSION AND/OR ECTOPIC CLIP BINDING | 2020-03-05 |
20200069767 | NOVEL COMPOUNDS AND THERAPEUTICS USES THEREOF | 2020-03-05 |
20200069768 | GLYCOPEPTIDE COMPOSITIONS | 2020-03-05 |
20200069769 | METHODS OF TREATING INFLAMMATORY DISORDERS WITH MULTIVALENT FC COMPOUNDS | 2020-03-05 |
20200069770 | TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH APOLIPOPROTEIN MIMETICS | 2020-03-05 |
20200069771 | INHIBITING SPROUT ANGIOGENESIS | 2020-03-05 |
20200069772 | METHODS OF TREATING EARLY RHEUMATOID ARTHRITIS | 2020-03-05 |
20200069773 | Proteinaceous Complexes and Uses Thereof | 2020-03-05 |